Safinamide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Safinamide. Educational only — not medical advice.
Labeled uses
XADAGO is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episodes.
Source: FDA labeling via NIH DailyMed (set c4d65f28…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.